Home
About
Overview
Sharing Data
ORCID
Help
History (1)
EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy.
EGR1 Haploinsufficiency Confers a Fitness Advantage to Hematopoietic Stem Cells Following Chemotherapy. Exp Hematol. 2022 11; 115:54-67.
View in:
PubMed
subject areas
Aged
Animals
Antigens, CD34
Early Growth Response Protein 1
Ethylnitrosourea
Haploinsufficiency
Hematopoietic Stem Cells
Humans
Inflammation
Mice
authors with profiles
Megan Mcnerney
Angela Stoddart